STASON PHARMS
SpecialtySTASON PHARMS is a specialty pharmaceutical company focused on Oncology.
STASON PHARMS's Key Drugs
STASON PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
STASON PHARMS's Recent FDA Approvals
New NDA/BLA approvals for STASON PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
STASON PHARMS's Therapeutic Areas
STASON PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Oncology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
STASON PHARMS's Top Competitors
STASON PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
STASON PHARMS Pipeline Snapshot
Active clinical trials for STASON PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1953-09-11
- Latest
- 2024-07-09
- Applications
- 1